Jane Street’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$159K Buy
57,696
+46,986
+439% +$146K ﹤0.01% 10341
2025
Q4
$33.6K Buy
+10,710
New +$33.8K ﹤0.01% 10622
2025
Q1
Sell
-24,283
Closed -$65.6K 9297
2024
Q4
$65.6K Buy
+24,283
New +$75.9K ﹤0.01% 8906
2024
Q2
Sell
-14,418
Closed -$42.7K 9242
2024
Q1
$42.7K Buy
+14,418
New +$51.7K ﹤0.01% 8777
2023
Q1
Sell
-42,581
Closed -$86.9K 8911
2022
Q4
$86.9K Buy
+42,581
New +$110K ﹤0.01% 8172
2019
Q2
Sell
-11,116
Closed -$56K 5058
2019
Q1
$56K Buy
+11,116
New +$70.7K ﹤0.01% 4822

Other funds holding ACIU

Jane Street's ACIU Position: Q1 2026 in Review

Jane Street increased its AC Immune (ACIU) stake by 439% in Q1 2026, buying an estimated $146K and bringing the position to 57,696 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #10341.

Jane Street first reported a position in ACIU in Q1 2019 and has held it in 6 quarters since. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • Jane Street held 57,696 shares of AC Immune worth $159K as of Q1 2026.
  • Jane Street bought 46,986 AC Immune shares in Q1 2026, an estimated $146K.
  • AC Immune made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10341 holding.
  • Jane Street first reported a position in AC Immune in Q1 2019 and has held it in 6 quarters since.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.